Marek Health and Maximus both put a prescribing physician between a man and testosterone therapy, and both retest on a defined schedule. The similarity ends at the product shape. Marek Health sells access to a deep a la carte lab menu with a physician and a separate coach, billing each panel and each medication as its own line. Maximus sells named protocols at a monthly rate, with the enclomiphene protocol as its distinguishing option.
The decision usually turns on one clinical question and one commercial one. The clinical question is whether preserving fertility matters. The commercial question is how many lab panels you expect to run in the next twelve months.
The Verdict
What each platform actually is
Marek Health
Marek Health sells a physician-led optimization service with a coaching layer on top. Two people are involved: a coach who works through your results with you, and a physician who owns the prescribing. Labs come from an a la carte menu, the deepest in the physician-led telehealth category, drawn at a partner lab. That means a venous blood draw rather than a home kit. The prescription list covers testosterone, select peptides, and ancillaries such as aromatase inhibitors and HCG where clinically indicated. Retesting runs every 8 to 12 weeks during active titration. Because labs and medication are not bundled into a flat fee, the platform does not produce a single quotable annual price.
Maximus
Maximus sells hormone optimization for men organized around named protocols rather than an open-ended clinical relationship. Each protocol carries a monthly price of $150 to $300 or more, covering the medication and the ongoing clinician oversight. The initial assessment and lab work are typically billed separately and vary by market. Its enclomiphene protocol is the option that separates it from the rest of the category: enclomiphene is a selective estrogen receptor modulator that blocks estrogen feedback at the hypothalamus, raising LH and FSH so the testes produce more testosterone themselves. A conventional testosterone protocol is also offered, priced in the same band. The panel is hormone-focused and protocol-specific rather than general.
Side by side on the standard rubric
The same ten criteria used on every platform page. The two columns diverge most on how the bill is assembled, on prescription breadth, and on which mechanism is available.
| Criterion | Marek Health | Maximus |
|---|---|---|
| Annual price (entry) | $2,500 to $6,000+/yr all-in | $150 to $300+/mo plus labs (~$2,000 to $4,000 year one) |
| Biomarkers (base panel) | A la carte, deep menu | Hormone-focused, protocol-specific |
| Physician access | Bundled, physician-led plus a coach | Bundled, telehealth physician |
| Prescription pathway | Testosterone, peptides, ancillaries | Enclomiphene or testosterone, per named protocol |
| Retest cadence | Every 8 to 12 weeks per protocol | Titration labs at 6 to 12 weeks, then maintenance |
| Ongoing reassessment | Coaching plus physician dose management | Protocol-driven physician oversight |
| Draw type | Partner lab, venous draw | Lab draw, typically billed separately |
| Hidden costs | Every lab and medication is a line item | Initial assessment and lab work sit outside the monthly figure |
| Public litigation | None publicly identified (as of Aug 2026) | None publicly identified (as of Aug 2026) |
| Best for | Men on hormone or peptide protocols who choose their own panels | Men raising testosterone while preserving fertility |
What each actually costs
| Cost layer | Marek Health | Maximus |
|---|---|---|
| Entry cost | $200 to $400 initial physician consult, then about $99/mo coaching | Initial assessment and baseline labs, billed separately and varying by market |
| Lab work | Baseline panel $400 to $800; follow-up panels $200 to $500 every 8 to 12 weeks | Titration labs at 6 to 12 weeks, then a maintenance cadence, billed separately |
| Medication | Priced by protocol, billed per prescription | Included in the $150 to $300+/mo protocol fee alongside clinician oversight |
| Realistic year one | $2,500 to $6,000+ depending on lab depth and protocol | ~$2,000 to $4,000 including the assessment and two rounds of labs |
| Year two (ongoing) | ~$2,300 to $5,600+ once the one-time consult falls away | ~$1,800 to $3,600 for the protocol plus maintenance labs |
| What moves the number most | How many panels you choose to run | Which protocol you are on, and local lab pricing |
Marek Health's year-one figure is assembled rather than quoted. The initial physician consult runs $200 to $400, coaching about $99 a month, a comprehensive baseline panel $400 to $800, and each follow-up panel $200 to $500 at an 8 to 12 week cadence. That is roughly four to six panels in a first year of active titration, with medications priced by protocol on top. The $2,500 to $6,000 range comes from that arithmetic, and year two drops to about $2,300 to $5,600 once the one-time consult falls away.
Maximus prices the protocol rather than the panel. The monthly $150 to $300 or more covers medication and clinician oversight together, which is why the figure looks small next to a Marek Health panel. The assessment and the labs sit outside it and vary by market. A realistic first year lands near $2,000 to $4,000 including two rounds of lab work, falling to about $1,800 to $3,600 in year two without the initial assessment.
Where Marek Health leads
- Lab menu depth. The a la carte menu is the deepest in the physician-led telehealth category, so a protocol question can be answered with a specific marker rather than an inference.
- Prescription breadth. Beyond testosterone, clinicians can prescribe select peptides and ancillaries including aromatase inhibitors and HCG where clinically indicated.
- Sustained retest cadence. Panels every 8 to 12 weeks continue through an active protocol rather than tapering to maintenance after titration.
- A separate coaching layer. A coach reads results with you between physician touchpoints, which is a distinct role from the one signing the prescription.
- Panel control. You decide which markers get run, so spending can be concentrated where a protocol question actually sits.
Where Maximus leads
- A fertility-preserving mechanism as standard. Enclomiphene raises testosterone by signalling the testes, so sperm production and testicular volume are preserved rather than suppressed.
- Medication inside the monthly fee. The protocol price covers the medication and the clinician oversight together, so the largest recurring line is not a separate bill.
- Lower realistic first year. Roughly $2,000 to $4,000 all-in sits below the $2,500 to $6,000 Marek Health range at both ends.
- No panel selection required. Protocols are defined, so onboarding does not ask a first-time patient to choose which labs to run.
- Lighter maintenance phase. Once titration finishes, monitoring moves to a maintenance cadence rather than continuing at the titration frequency.
Trade-offs to weigh
Marek Health trade-offs
- The price is not quotable up front. A la carte billing means the year-one number depends on panels you have not chosen yet, anywhere from $2,500 to $6,000 or more.
- It expects your participation. The model works best when you can help decide which labs to run, which is a real demand on someone new to hormone therapy.
- Draws, not mail-in. Every panel is a venous draw at a partner lab on their schedule, as many as six trips in a year at the faster cadence.
- Still hormone-first in scope. Depth on hormones and peptides does not make it a general longevity program, and cardiovascular and metabolic work is less central.
Maximus trade-offs
- Eligibility is not universal. Enclomiphene needs testes that can respond. In primary hypogonadism, where LH is already high and testosterone remains low, the mechanism has little to work with.
- Labs sit outside the monthly figure. The assessment and every panel are billed separately and vary by market, so the quoted monthly rate is not the all-in cost.
- Narrow prescription list. Care is organized around named protocols, so peptides, GLP-1s, and a wider ancillary list are outside the product.
- Protocol-specific panel. The markers run are those a protocol needs, so lipids, inflammation, and nutrient status are not covered.
Who should pick each
Pick Maximus if: you want children now or later, or you want the option to stop treatment without a recovery period. Your baseline LH and FSH suggest the mechanism is available to you. You want the monthly number to include medication, you are content with a defined protocol rather than a panel you assemble, and your questions stop at hormones. A first year near $2,000 to $4,000 fits the budget.
Pick Marek Health if: you are already on a hormone protocol or heading into a complex one, and you want peptides or ancillaries managed alongside it. You want a physician moving your dose on panels every 8 to 12 weeks, and you want to choose which markers those panels carry. You will show up for venous draws, you want a coach working through results between physician visits, and you can absorb a year anywhere between $2,500 and $6,000.
Who should pick neither
Both platforms begin from the premise that hormones are the problem. If that has not been established, treating testosterone first can settle a number while leaving the cause in place. Thyroid dysfunction, iron deficiency, untreated sleep apnea, and depression all produce the flat energy, low libido, and poor recovery that send men to a hormone clinic, and neither platform's panel is designed to separate them.
- An in-network primary care workup. A physical with a comprehensive metabolic panel, thyroid markers, ferritin, and a morning total and free testosterone often costs a copay and rules several causes in or out before any membership.
- A sleep evaluation, if the fatigue comes with snoring or unrefreshing sleep. Untreated sleep apnea is a recognized contributor to both daytime fatigue and suppressed testosterone, and no telehealth hormone panel detects it.
- A broad biomarker panel first. Function Health measures 100-plus markers for $499 a year, which covers the imitators a hormone-scoped panel omits. Our Function Health review has the detail.
- A urologist, if fertility is the actual question. A semen analysis measures sperm concentration and motility directly, and neither platform can order one.
What the rubric does not capture
The rubric records that both platforms include a physician. It does not record how the relationship is shaped. Marek Health asks you to maintain two relationships, a coach and a prescriber, which means more total attention and more of your time spent inside the platform. Maximus routes everything through one protocol-driven clinical relationship, which is lighter to manage and offers fewer places to raise a question that falls outside the protocol.
Month six also looks different on each. On Marek Health, the a la carte structure either earns its cost because each panel keeps changing something, or starts billing for panels that report the same result. On Maximus, month six is usually the maintenance phase, where the monthly protocol fee continues while monitoring lightens. Applying the same ten-criteria rubric across every platform on this site, the pattern that recurs is this: cost per unit of feedback separates programs more than headline price does, and no comparison row shows it because it lives between the price row and the cadence row.
The rubric also cannot record eligibility. Every other row on this page describes a choice a buyer makes. The enclomiphene row describes a choice physiology makes first, and it is the one row a reader can resolve for themselves before contacting either platform.
Frequently Asked Questions
Is Marek Health better than Maximus?
Neither is better in general, because they answer different questions. Maximus is built around named protocols and offers enclomiphene as a standard option, which raises testosterone while preserving sperm production. Marek Health is built around a deep a la carte lab menu with a physician and a coach, and prescribes testosterone, select peptides, and ancillaries. If fertility preservation is the constraint, Maximus is designed for it. If a protocol spans more than testosterone and needs frequent panels, Marek Health is designed for that.
Which is cheaper, Marek Health or Maximus?
Maximus, at both the entry point and across a realistic first year. Maximus protocols run $150 to $300 or more monthly with medication and clinician oversight included, landing near $2,000 to $4,000 in year one once the assessment and two rounds of labs are added. Marek Health starts with a $200 to $400 consult, adds about $99 a month for coaching, and bills each panel at $400 to $800 for the baseline and $200 to $500 for follow-ups, reaching $2,500 to $6,000 or more. The gap is lab volume rather than clinician time.
Maximus vs Marek Health for fertility, which one?
Maximus offers enclomiphene as a standard protocol option, and enclomiphene is the mechanism most directly aimed at this concern. It is a selective estrogen receptor modulator that blocks estrogen feedback at the hypothalamus, raising LH and FSH so the testes keep producing testosterone themselves. Marek Health approaches the same concern differently, prescribing HCG alongside testosterone where clinically indicated, which mimics LH at the testes. Both routes are prescriber judgements that depend on baseline LH and FSH, and neither platform can order a semen analysis, which measures the outcome directly.
Which one prescribes peptides?
Marek Health has the broader prescription list, covering testosterone, select peptides, and ancillaries such as aromatase inhibitors and HCG where clinically indicated. Maximus is organized around named protocols rather than an open prescription list, so peptide breadth is not part of the product. If a peptide protocol is part of the plan, that narrows the choice before price does.
Which retests more often?
They are close during the adjustment window and diverge afterwards. Marek Health panels every 8 to 12 weeks throughout an active protocol, roughly four to six panels in a first year. Maximus runs titration labs at 6 to 12 weeks and then moves to a maintenance cadence, so early monitoring is comparable and later monitoring is lighter. The practical difference is what a panel costs when you want an extra one: on Marek Health each additional panel is $200 to $500, and on Maximus lab pricing depends on your market.
Am I eligible for the Maximus enclomiphene protocol?
That depends on baseline LH and FSH, and it is a prescriber decision rather than a purchase decision. Enclomiphene works by signalling the testes to produce more testosterone, so it needs testes capable of responding. Low testosterone with low or normal LH points at secondary hypogonadism, where the pituitary signal is weak and there is something to amplify. Low testosterone with high LH points at primary hypogonadism, where the signal is already strong and unanswered. Ask for the LH and FSH values from any panel you already have before comparing platforms.
Can I use both at the same time?
Running both duplicates the same care. Each bundles a prescribing clinician and each monitors the same hormone axis, so a simultaneous stack pays twice to manage one protocol. It also puts two prescribers on one patient, and a clinician adjusting testosterone needs to know the whole dose. Sequential use is the workable version: start where the mechanism fits, and move if the protocol outgrows the platform.
What happens if I cancel mid-protocol?
Cancelling ends the prescription without ending the physiology, on either platform. Exogenous testosterone suppresses the body's own LH and FSH signalling, so coming off it is a clinical taper question. Enclomiphene acts on the same loop from the other direction, so stopping it is also a prescriber conversation rather than a subscription setting. Raise the exit plan with the prescribing clinician before you cancel, and keep the membership active until any incoming clinician has a baseline draw in hand.